104 related articles for article (PubMed ID: 17470879)
1. Elementary, my dear Watson.
García-Saénz JA; Martín M; Díaz-Rubio E
J Clin Oncol; 2007 May; 25(13):1815-6. PubMed ID: 17470879
[No Abstract] [Full Text] [Related]
2. [Palliative chemotherapy for metastatic breast cancer with capecitabine].
Inaba T; Kashiwaba M; Takeda Y; Komatsu H; Tomisawa Y; Takiyama I; Wakabayashi G
Gan To Kagaku Ryoho; 2009 May; 36(5):769-72. PubMed ID: 19461175
[TBL] [Abstract][Full Text] [Related]
3. Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients?
Kurt M; Aksoy S; Guler N
Acta Oncol; 2006; 45(5):625-6. PubMed ID: 16864181
[No Abstract] [Full Text] [Related]
4. Severe palmar-plantar erytrodysesthesia after treatment with capecitabine.
López V; Martín JM; Jordá E
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):106-8. PubMed ID: 19614859
[No Abstract] [Full Text] [Related]
5. Cerebellar toxicity with capecitabine in a patient with metastatic breast cancer.
Mukesh M; Murray P
Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):382-3. PubMed ID: 18407475
[No Abstract] [Full Text] [Related]
6. [Capecitabine: an oral chemotherapeutic agent against metastatic breast and colorectal cancer].
Calzas Rodríguez J; de la Nogal Fernández B; Arrieta Garmendia JM; Lastra Aras E; García Castaño A; Barrio Gil-Fournier A; García Girón C
Farm Hosp; 2003; 27(3):171-8. PubMed ID: 12835819
[TBL] [Abstract][Full Text] [Related]
7. Lapatinib: new drug. For some women with metastatic breast cancer.
Prescrire Int; 2009 Feb; 18(99):9. PubMed ID: 19382400
[No Abstract] [Full Text] [Related]
8. [A woman with palmar and plantar hyperpigmentation].
van Tienhoven G; Wilmink JW
Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
[TBL] [Abstract][Full Text] [Related]
9. Trastuzumab and capecitabine for metastatic breast cancer.
Med Lett Drugs Ther; 1998 Nov; 40(1039):106-8. PubMed ID: 9814369
[No Abstract] [Full Text] [Related]
10. [Adjuvant chemotherapy in older women with breast cancer. CALGB Study (The Cancer and Leukemia Group B Study)].
Mallmann P; Nitschmann S
Internist (Berl); 2010 Jul; 51(7):923-4. PubMed ID: 20544172
[No Abstract] [Full Text] [Related]
11. Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.
Huang H; Jiang Z; Wang T; Zhang S; Bian L; Cao Y; Wu S; Song S
Anticancer Drugs; 2012 Aug; 23(7):718-23. PubMed ID: 22739713
[TBL] [Abstract][Full Text] [Related]
12. Study of low-dose capecitabine monotherapy for metastatic breast cancer.
Taguchi T; Nakayama T; Masuda N; Yoshidome K; Akagi K; Nishida Y; Yoshikawa Y; Ogino N; Abe C; Sakamoto J; Noguchi S;
Chemotherapy; 2010; 56(2):166-70. PubMed ID: 20407245
[TBL] [Abstract][Full Text] [Related]
13. Impact of prophylactic pyridoxine on occurrence of hand-foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer.
Yoshimoto N; Yamashita T; Fujita T; Hayashi H; Tsunoda N; Kimura M; Tsuzuki N; Yamashita H; Toyama T; Kondo N; Iwata H
Breast Cancer; 2010 Oct; 17(4):298-302. PubMed ID: 19789949
[TBL] [Abstract][Full Text] [Related]
14. Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer.
Quek R; Lim WT; Foo KF; Koo WH; A-Manaf A; Toh HC
Acta Oncol; 2007; 46(7):1032-4. PubMed ID: 17917832
[No Abstract] [Full Text] [Related]
15. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
Ghosal N; Misra V
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
[No Abstract] [Full Text] [Related]
16. Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer.
Layman RM; Thomas DG; Griffith KA; Smerage JB; Helvie MA; Roubidoux MA; Diehl KM; Newman LA; Sabel MS; Hayman JA; Pierce LJ; Hayes DF; Schott AF
Clin Cancer Res; 2007 Jul; 13(14):4092-7. PubMed ID: 17634534
[TBL] [Abstract][Full Text] [Related]
17. Dose-finding study of capecitabine in combination with weekly paclitaxel for patients with anthracycline-pretreated metastatic breast cancer.
Susnjar S; Bosnjak S; Radulovic S; Stevanovic J; Gajic-Dobrosavljevic M; Kreacic M
J BUON; 2007; 12(2):189-96. PubMed ID: 17600871
[TBL] [Abstract][Full Text] [Related]
18. Hand-foot syndrome related to chemotherapy.
Qiao J; Fang H
CMAJ; 2012 Oct; 184(15):E818. PubMed ID: 22508979
[No Abstract] [Full Text] [Related]
19. Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study.
Tanaka M; Takamatsu Y; Anan K; Ohno S; Nishimura R; Yamamoto Y; Masuda N; Mitsuyama S; Tamura K;
Anticancer Drugs; 2010 Apr; 21(4):453-8. PubMed ID: 20075712
[TBL] [Abstract][Full Text] [Related]
20. Images in clinical medicine. Loss of fingerprints.
Chavarri-Guerra Y; Soto-Perez-de-Celis E
N Engl J Med; 2015 Apr; 372(16):e22. PubMed ID: 25875278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
